| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |